Clinical Trials in Washington

Showing 1481-1500 of 4,564 trials

High Dose Flu Vaccine in Treating Children Who Have Undergone Donor Stem Cell Transplant

NCT02860039

This phase II randomized trial studies how well high dose flu vaccine works in treating children who have undergone done stem cell transplant. Higher dose flu vaccine may build a better immune response and may provide better protection against the flu than the standard vaccine.

Hematopoietic Cell Transplantation RecipientMalignant NeoplasmInfluenza

Vanderbilt-Ingram Cancer Center170 participantsStarted Sep 2016

San Francisco, California, United States • Kansas City, Missouri, United States • Cincinnati, Ohio, United States +6 more locations

COMPLETEDPhase 242 miles

Cytomegalovirus (CMV) Vaccine in Donors and Recipients Undergoing Allogeneic Hematopoietic Cell Transplant (HCT)

NCT00285259

The purpose of this trial is to evaluate a CMV vaccine given to related donor/recipient pairs (donors prior to peripheral blood stem cell donation and CMV-seropositive recipients just before and after transplantation) and CMV-seropositive recipient-only subjects (related or unrelated) to determine incidence rates of CMV infection, disease, and other complications from immunosuppression and/or transplantation. The outcomes for the groups receiving CMV vaccine will be compared to the outcomes for the group that received the placebo vaccine to see if there is a clinical benefit. For this trial, donors and recipients must have matched HLA genotype (matched at 5/6 or 6/6 HLA loci).

Acute Lymphoblastic LeukemiaChronic Myelogenous LeukemiaAcute Myelogenous Leukemia+3 more

Astellas Pharma Inc112 participantsStarted Jan 2006

Tucson, Arizona, United States • Duarte, California, United States • Denver, Colorado, United States +19 more locations

High Dose Flu Vaccine in Treating Children Who Have Undergone Donor Stem Cell Transplant

Cytomegalovirus (CMV) Vaccine in Donors and Recipients Undergoing Allogeneic Hematopoietic Cell Transplant (HCT)

Find Trials by Condition in Washington

SL-401 as Consolidation Therapy in Patients With Adverse Risk Acute Myeloid Leukemia in First Complete Remission

Atrasentan in Patients With IgA Nephropathy

Open- Label Trial of Sipuleucel-T Administered to Active Surveillance Patients for Newly Diagnosed Prostate Cancer

Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment

Open-Label Extension Study of Trofinetide for Rett Syndrome

Environmental Toxicants Avoidance Study

Milademetan in Advanced/Metastatic Solid Tumors

Pharmacokinetics of Oral Mirabegron With Different Release Rates Versus Intravenous (IV) Mirabegron

Comparative Effectiveness of Direct Admission & Admission Through Emergency Departments for Children

Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis

Study of LAU-7b in the Treatment of Cystic Fibrosis in Adults

Observational Study of Obstructive Lung Disease (NOVELTY)

A Study to Learn About The Study Medicine (PF-07038124) In Patients With Mild To Moderate Atopic Dermatitis Or Mild To Severe Plaque Psoriasis.

Caspofungin Acetate, Fluconazole, or Voriconazole in Preventing Fungal Infections in Patients Following Donor Stem Cell Transplant

Inhaled Imatinib Pulmonary Arterial Hypertension Clinical Trial - Follow Up Long Term Extension (IMPAHCT-FUL)

TriVerity in the Diagnosis and Prognosis of Emergency Department Patients With Suspected Infections and Suspected Sepsis

Safety and Efficacy of IMC-C103C as Monotherapy and in Combination With Atezolizumab

Virtual Reality Glove for Hand and Arm Rehabilitation After Stroke